Jane Wasman

Currently, Ms. Wasman serves as President, International and General Counsel at Acorda Therapeutics where she is responsible for global strategic development, leading long-range planning and development in addition to international expansion, and the legal and compliance functions. In her role, she collaborates with senior leadership on commercialization, licensing, product pipeline development, and government affairs activities. Prior to joining Acorda, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and Associate General Counsel. Previously, she was an attorney at two global law firms and Associate Counsel for the U.S. Senate Veterans' Affairs Committee. Ms. Wasman is Chair of the Board of Sellas Life Sciences, an oncology-focused biotech company, and also serves on the board of the non-profit NewYorkBIO. Ms. Wasman graduated magna cum laude from Princeton University, and earned her J.D. from Harvard Law School